Vera Therapeutics, Inc.
VERA
$36.70
$0.090.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -134.13% | -109.78% | -72.18% | -127.04% | -82.13% |
| Total Depreciation and Amortization | 64.71% | 145.45% | 437.50% | 693.33% | 672.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 323.43% | 115.74% | 147.98% | 197.51% | 110.09% |
| Change in Net Operating Assets | -45.45% | 1,523.35% | 48.15% | 117.81% | -9.50% |
| Cash from Operations | -95.75% | -78.64% | -67.84% | -121.12% | -60.82% |
| Capital Expenditure | 87.70% | 84.19% | 44.12% | -133.71% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -988.76% | 136.59% | 81.28% | 227.29% | 107.07% |
| Cash from Investing | -999.76% | 136.44% | 82.06% | 225.87% | 106.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 157.14% | -12.42% | 5.98% | -86.51% | -99.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 16.16% | -- | -- | -- |
| Cash from Financing | 157.14% | -12.17% | 7.85% | 489.85% | -99.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -540.04% | 354.12% | 298.53% | 86.44% | -260.33% |